The FY23 Defense Appropriations Act provides funding for the Rare Cancers Research Program to support research of exceptional scientific merit in the area of rare cancers research.
The RCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY23 funding opportunities. The FY23 RCRP funding opportunity announcements for the following award mechanisms will be posted on the Grants.gov website.
Applications submitted to the FY23 RCRP Concept Award and Idea Development Award must address one or more of the following focus areas:
- Biology and Etiology: Identify disease-defining molecular pathways, cell context, and microenvironment.
- Research Model: Develop and validate rare tumor-specific models that can support clinical trial readiness.
- Therapy: Identify novel therapeutic strategies, including drug repurposing.
Applications submitted to the FY23 RCRP Resource and Community Development Award must address the focus areas:
- Platform Development: Development of platforms (such as tumor tissue repository with clinical annotation, centralized databanks, patient registry with common data structure, research model and “omics” database, and longitudinal studies of natural history and treatment response) for multiple rare cancers to allow sharing of data, bio-specimens, and resources.
More information about award mechanisms, eligibility, and funding can be found here.
